CLINICAL_TRIALS
trial_result
· 2016-06-30
Clinical Trial Update: Safety Study of TissueGene-C in Degenerative Joint Disease of the Knee [Phase 1]
Summary
Phase 1 safety study of TissueGene-C for osteoarthritis of the knee has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kolon TissueGene, Inc. | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED | Results posted: 2016-06-30